News
Stay Ahead with the Latest Industry Trends & Market Insights with Industry News 📰

Chondroitin Sulfate Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: February 2024 || SKU: PH4139
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Get Free Sample

See how US Tariffs impact Chondroitin Sulfate Market

Don’t get caught off guard! See what’s changin

Global Chondroitin Sulfate Market is Segmented By Source (Swine,  Shark, Bovine, Synthetic, Others),  By Application (Pharmaceuticals, Cosmetics, Veterinary), By Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Other), By Region (North America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
 

Chondroitin Sulfate Market Overview

The global chondroitin sulfate market is estimated to reach at a CAGR of 5% during the forecast period (2024-2031). Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars like N-acetylgalactosamine and glucuronic acid. It is a natural chemical component of human connective tissues that are generally found in cartilage around bone joints in the human body. Chondroitin sulfate is generally manufactured from the animal source, such as bovine, porcine, shark and other marine sources. Chondroitin sulfate is an alternative medicine for slowing the progression of osteoarthritis.

Chondroitin Sulfate Market Summary and Scope

Metrics

Details

Market CAGR

5%

Segments Covered

By Source, By Application, By Distribution Channel, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

 

To Get a Free Sample Click here

 

Chondroitin Sulfate Market Dynamics and Trends

The global chondroitin sulfate market growth is driven by the rising awareness towards joint health and the introduction of novel chondroitin sulfate combination products.

Increasing demand for nutraceutical products is expected to drive growth in the forecast period

Sodium chondroitin sulfate is used in dietary supplements and food products as thickeners, additives, forming agents, preservatives, in health food, and in animal feed.  It is extensively used due to its ability to treat pets suffering from joint pain and arthritis, including diseases such as chronic pain and aches from osteoarthritis, elbow dysplasia, and hip dysplasia. Food grade and animal feed grade applications are presumed to drive the market growth in the forecast period.

It is also used to improve digestive function, enhance liver function, lower blood sugar, and inhibit tumor metastasis. The growing popularity of its use in the treatment of osteoarthritis and several other treatments is expected to benefit the overall market growth.

Growth in the pharmaceutical and personal care industry is expected to drive the market growth

Growth in the pharmaceutical and personal care industry owing to changing lifestyles and increasing healthcare expenditure may foster the product demand. The rising application of chondroitin sulfate in medicines is to cure joint pain and inflammation, which may drive the overall market growth. Growth in the personal care industry owing to increasing personal care expenditure may drive the product market size. The product is used in skin and hair repair creams and lotions owing to its ability to moisturize, heal and soothe skin. Chondroitin sulfate is also used in skincare products owing to its benefits such as anti-inflammatory properties and skin’s intercellular matrix reinforcement ability, thereby stimulating the product demand.

Regulatory obstruction is likely to hinder the market growth

However, religious & cultural impediments on the usage of chondroitin sulfate (Middle Eastern countries) are a few of the factors restricting the growth of the global chondroitin sulfate market.

COVID-19 Impact Analysis on Chondroitin Sulfate Market

The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on society and affecting millions of people and businesses. Due to the diversion of the medical field towards treating COVID-19, the funding to R&D activities related to chondroitin sulfate has been reduced and this segment has to face negligence subsequently causing a negative impact on chondroitin sulfate market. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing chondroitin sulfate market landscape.

Chondroitin Sulfate Market Segmentation Analysis

The pharmaceuticals segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)      

Chondroitin sulfate is majorly used for the treatment of osteoarthritis. It is often used in combination with other ingredients such as glucosamine sulfate, manganese ascorbate, N-acetyl glucosamine or glucosamine hydrochloride. Chondroitin sulfate is also taken orally for heart attack, HIV/AIDS, heart disease, osteoporosis, joint pains because of the drugs used in the treatment of breast cancer, high cholesterol, muscle soreness after exercise, acid reflux, interstitial cystitis, Kashin-Beck disease, and psoriasis.

Chondroitin sulfate is approved by the FDA as an eye drops to treat dry eyes and is also used as a solution to preserve cornea during cataract surgery. In 2017, Imprimis Pharmaceuticals Inc., an ophthalmology-focused pharmaceutical company, announced that it has entered into a licensing agreement for the exclusive worldwide rights to Klarity, ophthalmic topical solution, and gel technology for patients with a dry eye disease (DED).

Chondroitin sulfate ointments in combination with glucosamine sulfate, shark cartilage, and camphor can be used for the pain of osteoarthritis. Some patients will inject chondroitin sulfate into muscles for osteoarthritis and some will insert chondroitin sulfate into the bladder for urinary tract infections, bladder conditions, or loss of bladder control. Thus there is a wide range of medicinal applications of chondroitin sulfate, the respective segment is expected to grow significantly.

The hospital pharmacy is expected to dominate the chondroitin sulfate market during the forecast period

The hospital pharmacies held the largest share in the chondroitin sulfate market. This is mainly owing to the increasing number of patients suffering from conditions that are treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, the growing number of hospitals along with adequate reimbursement policies is also contributing to the growth of this segment.

Chondroitin Sulfate Market Geographical Share

North America region holds the largest market share global chondroitin sulfate market

The well-established pharmaceutical industry in the NorthAmerica region and increasing USFDA approvals for chondroitin sulfate will drive the growth of the chondroitin sulfate market in the region.

The increased use of osteoarthritis in cataract surgery and formulations for a drop in the eye are also a few factors that are enhancing the growth of the market in North America. In November 2017, Gnosis launched the first dietary supplements with Mythocondro, the unique 100% vegan chondroitin sulfate similar to human synovial fluid into the USA market. Furthermore, increasing demand for anti-ageing products is likely to further propel regional industry growth. The population of elderly people is expected to surpass over 173 million by 2026, which are more prone to orthopedic diseases. Chondroitin sulfate is used to cure orthopedic diseases like osteoporosis and osteoarthritis, which may boost the regional product demand.

Chondroitin Sulfate Companies and Competitive Landscape

The chondroitin sulfate market is moderately competitive with the presence of local as well as global companies.  Some of the key players which are contributing to the growth of the market include are FIDIA FARMACEUTICI S.P.A, GNOSIS S.p.A., Merck KGaA (Sigma-Aldrich, Inc), Synutra, Inc., Summit Nutritionals International, Nutramax Laboratories Inc., Bioiberica S.A.U, Pacific Rainbow International, Yantai Ruikangda Biochemical Products Co., Ltd., TSI Group Ltd among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the chondroitin sulfate market globally.   

Chondroitin Sulfate Market Key Companies to Watch  

Pacific Rainbow Inc

Overview: Pacific Rainbow International Inc, which was established in 1995 in California, is a supplier in Chondroitin Sulfate (90% for any testing methods), Glucosamine Hcl /Sulfate, MSM, DHEA, Biotin, Inostitol Nicotinate Alpha Lipoic Acid etc. The international first-class Heparin Sodium and Chondroitin sulphate Workshops are completely complying with GMP which ensure that our product quality ranking is in the leading position in this line. Our effective access to raw materials.

Product Portfolio: The Company’s portfolio is comprised of wholesale distribution of paints, varnishes, wallpaper, and supplies.

Why Purchase the Report?

  • Visualize the composition of the chondroitin sulfate market segmentation by source, application, distribution channel, and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in the chondroitin sulfate market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of chondroitin sulfate market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global chondroitin sulfate market report would provide an access to an approximately 45+ market data table, 40+ figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers
Buy this report
Single User
$4350$3480
Multiple User
$4850$3880
Enterprise User
$7850$6280
Proceed to Buy
  Get Free Sample
  Request new version
  Customize Sample
  Demo Full Report
Chat on WhatsApp
FAQ’s

  • Chondroitin Sulfate Market is expected to grow at a CAGR of 5.0% during the forecasting period 2024-2031.

  • North America region Controls the Chondroitin Sulfate Market during 2024-2031.

  • The major drivers of the U.S. mono-ethylene glycol market include the extensive demand for PET (polyethylene terephthalate) and its growing applications in textiles, packaging, and other industries.

  • Some of the key players which are contributing to the growth of the market include are FIDIA FARMACEUTICI S.P.A, GNOSIS S.p.A., Merck KGaA (Sigma-Aldrich, Inc), Synutra, Inc., Summit Nutritionals International, Nutramax Laboratories Inc., Bioiberica S.A.U, Pacific Rainbow International, Yantai Ruikangda Biochemical Products Co., Ltd., TSI Group Ltd
Related Reports
pharmaceuticals iconpharmaceuticals

Venous Diseases Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 05

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Europe Liver Cancer Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 05

Starting from

$3750

pharmaceuticals iconpharmaceuticals

Europe Ovarian Cancer Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 October 23

Starting from

$3750

pharmaceuticals iconpharmaceuticals

Europe Theranostics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 September 24

Starting from

$3750

pharmaceuticals iconpharmaceuticals

Dermatitis Dermocosmetic Products Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 05

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Multiple Myeloma Market Size, Share Analysis, Growth Insights and Forecast 2025-2033

Published: 2025 March 03

Starting from

$4350

WhatsApp